Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.1.9
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
OPERATING ACTIVITIES    
Net income $ 3,357us-gaap_NetIncomeLoss $ 1,669us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for doubtful accounts 5,774us-gaap_ProvisionForDoubtfulAccounts 6,534us-gaap_ProvisionForDoubtfulAccounts
Depreciation 3,626us-gaap_Depreciation 5,415us-gaap_Depreciation
Loss/(gain) on disposal of medical equipment 281us-gaap_ImpairmentOfLongLivedAssetsHeldForUse (47)us-gaap_ImpairmentOfLongLivedAssetsHeldForUse
Gain on sale of medical equipment (2,179)us-gaap_GainLossOnDispositionOfAssets (2,027)us-gaap_GainLossOnDispositionOfAssets
Amortization of intangible assets 2,516us-gaap_AmortizationOfIntangibleAssets 2,618us-gaap_AmortizationOfIntangibleAssets
Amortization of deferred debt issuance costs 623us-gaap_AmortizationOfFinancingCosts 620us-gaap_AmortizationOfFinancingCosts
Stock-based compensation expense 576us-gaap_ShareBasedCompensation 1,120us-gaap_ShareBasedCompensation
Deferred income tax expense 2,588us-gaap_DeferredIncomeTaxExpenseBenefit 1,180us-gaap_DeferredIncomeTaxExpenseBenefit
Changes in Assets - (Increase)/Decrease:    
Accounts receivable (5,377)us-gaap_IncreaseDecreaseInAccountsReceivable (8,720)us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories (524)us-gaap_IncreaseDecreaseInInventories 105us-gaap_IncreaseDecreaseInInventories
Other current assets (115)us-gaap_IncreaseDecreaseInOtherCurrentAssets 166us-gaap_IncreaseDecreaseInOtherCurrentAssets
Other assets 140us-gaap_IncreaseDecreaseInOtherNoncurrentAssets (92)us-gaap_IncreaseDecreaseInOtherNoncurrentAssets
Changes in Liabilities - Increase/(Decrease):    
Accounts payable and other liabilities (4,031)us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities (1,078)us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
NET CASH PROVIDED BY OPERATING ACTIVITIES 7,255us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations 7,463us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
INVESTING ACTIVITIES    
Purchases of medical equipment and property (6,162)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (4,723)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Purchases of intangible assets (3,543)us-gaap_PaymentsToAcquireIntangibleAssets (1,239)us-gaap_PaymentsToAcquireIntangibleAssets
Proceeds from sale of medical equipment and property 6,867us-gaap_ProceedsFromSaleOfProductiveAssets 3,800us-gaap_ProceedsFromSaleOfProductiveAssets
NET CASH USED IN INVESTING ACTIVITIES (2,838)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (2,162)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
FINANCING ACTIVITIES    
Principal payments on term loans and capital lease obligations (66,689)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations (4,504)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations
Cash proceeds from bank loans and revolving credit facility 61,853us-gaap_ProceedsFromRepaymentsOfDebt 36,166us-gaap_ProceedsFromRepaymentsOfDebt
Payments on revolving credit facility   (38,072)us-gaap_RepaymentsOfLongTermLinesOfCredit
Common stock repurchased to satisfy taxes on stock based compensation (204)us-gaap_PaymentsForRepurchaseOfCommonStock (79)us-gaap_PaymentsForRepurchaseOfCommonStock
NET CASH USED IN FINANCING ACTIVITIES (5,040)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (6,489)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net change in cash and cash equivalents (623)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (1,188)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents, beginning of year 1,138us-gaap_CashAndCashEquivalentsAtCarryingValue 2,326us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents, end of year 515us-gaap_CashAndCashEquivalentsAtCarryingValue 1,138us-gaap_CashAndCashEquivalentsAtCarryingValue
SUPPLEMENTAL DISCLOSURES    
Cash paid for interest 2,351us-gaap_InterestPaid 2,668us-gaap_InterestPaid
Cash paid for income taxes 298us-gaap_IncomeTaxesPaid 549us-gaap_IncomeTaxesPaid
NON-CASH TRANSACTIONS    
Additions to medical equipment and property 937us-gaap_CapitalExpendituresIncurredButNotYetPaid [1] 266us-gaap_CapitalExpendituresIncurredButNotYetPaid [1]
Medical equipment acquired pursuant to a capital lease $ 3,596us-gaap_CapitalLeaseObligationsIncurred $ 2,541us-gaap_CapitalLeaseObligationsIncurred
[1] Amounts consist of current liabilities for medical equipment that have not been included in investing activities. These amounts have not been paid for as of December 31, 2014 and 2013, respectively, but will be included as a cash outflow from investing activities for purchases of medical equipment and property when paid.